Skip to main content
Blackhawk Growth Corp. logo

Blackhawk Growth Corp. — Investor Relations & Filings

Ticker · BLR ISIN · CA09238B3083 LEI · 875500A5R3SVGXL39M70 CSE Financial and insurance activities
Open in API
Filings indexed 574 across all filing types
Latest filing 2021-09-04 Regulatory Filings
Country CA Canada
Listing CSE BLR

About Blackhawk Growth Corp.

https://www.blackhawkgrowthcorp.com/

Blackhawk Growth Corp. operates as an investment issuer, specializing in generating shareholder value through strategic investments in the technology and life sciences sectors. The company focuses on acquiring and developing assets, intellectual property, and projects related to medical technologies, pharmaceuticals, digital health, software, big data, and AI. Blackhawk seeks opportunities that demonstrate global scalability and potential for positive impact on health and human wellbeing. Its core strategy involves providing capital for R&D and commercialization, followed by value realization through mergers, acquisitions, divestments, or spin-outs and public listings on North American stock exchanges.

Recent filings

Filing Released Lang Actions
Material change report - English.pdf
Regulatory Filings
2021-09-04 English
News release - English.pdf
Regulatory Filings
2021-09-04 English
Material change report - English.pdf
Regulatory Filings Classification · 95% confidence The document is titled 'FORM 51-102F3 Material Change Report' and details a material change involving Blackhawk Growth Corp acquiring control of MindBio Therapeutics Pty Ltd. It includes a full description of the transaction, management team details, and transaction structure. The document is a regulatory filing specific to material changes under Canadian securities law (NI 51-102). It is not an annual or quarterly report, earnings release, or other financial report. It is not a proxy, voting result, or remuneration report. It is a formal disclosure of a material corporate event. This fits the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories. The document length is substantial and contains detailed information about the material change, consistent with a material change report filing.
2021-08-31 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement about Blackhawk Growth Corp.'s acquisition of MindBio Therapeutics Pty Ltd, including information about the transaction structure, management and scientific teams, and strategic rationale. It discusses the share purchase agreement, equity financing, and issuance of common shares as consideration. The content focuses on the acquisition and investment details rather than financial results, regulatory compliance, or governance disclosures. There is no indication that this is a full annual or interim report, audit report, earnings release, or other financial statement. The document is not a proxy solicitation, voting results announcement, or a regulatory filing of a routine nature. It is clearly an announcement of a capital transaction involving acquisition and financing activities. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length and detail support a high confidence in this classification.
2021-08-31 English
Material change report - English.pdf
Regulatory Filings
2021-08-27 English
News release - English.pdf
Regulatory Filings
2021-08-27 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.